Search - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly

Filter your results

178 Results
authFullName_s : Jean-Yves Blay

Proof-of-concept study evaluating a new tool for standardizing radiological assessment of tumor response to treatment in routine clinical practice.

Charles Mastier , Christelle de La Fouchardiere , Pierre-Étienne Heudel , Jérome Fayette , Matthieu Sarabi et al.
Journal of Clinical Oncology, 2019, 37 (15_suppl), pp.e18079-e18079. ⟨10.1200/JCO.2019.37.15_suppl.e18079⟩
Journal articles hal-02163278v1

Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond

Axel de Bernardi , Armelle Dufresne , Florence Mishellany , Jean-Yves Blay , Isabelle Ray-Coquard et al.
Cancers, 2022, 14 (4), pp.1064. ⟨10.3390/cancers14041064⟩
Journal articles hal-03867907v1
Image document

Toward A Paradigm Shift in Cancer Research & Innovation for Patients in France

C. Long , Pa Bonnet , D. Pérol , M. Hebbar , P. Barthélémy et al.
Journal of pharmacology & clinical research, 2017, 3 (4), ⟨10.19080/JPCR.2017.03.555616⟩
Journal articles hal-03608858v1

PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target

Francois Bertucci , Pascal Finetti , Audrey Monneur , Delphine Perrot , Christine Chevreau et al.
Molecular Oncology, 2019, 13 (7), pp.1577-1588. ⟨10.1002/1878-0261.12522⟩
Journal articles hal-02504850v1

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report

Romain Varnier , Thibaut Garrivier , Emilie Hafliger , Aymeric Favre , Clélia Coutzac et al.
Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.756365⟩
Journal articles hal-03811683v1

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma

Nuria Kotecki , Axel Le Cesne , Emmanuelle Tresch-Bruneel , Isabelle Ray-Coquard , Christine Chevreau et al.
American Journal of Clinical Oncology, 2018, 41 (11), pp.1094-1100. ⟨10.1097/coc.0000000000000430⟩
Journal articles hal-03623697v1

Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial

Patrick Schöffski , Jozef Sufliarsky , Hans Gelderblom , Jean-Yves Blay , Sandra J. Strauss et al.
The Lancet Respiratory Medicine, 2018, 6 (6), pp.431-441. ⟨10.1016/S2213-2600(18)30116-4⟩
Journal articles hal-01958081v1
Image document

Genetic Analysis in Anal and Cervical Cancer: Exploratory Findings About Radioresistance in the ProfiLER Database

Elise Rowinski , Nicolas Magne , Wafa Bouleftour , Pablo Moreno-Acosta , Christelle de La Fourchadiere et al.
Cancer Genomics and Proteomics, 2021, 18 (4), pp.515-520. ⟨10.21873/cgp.20276⟩
Journal articles hal-03323257v1

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib

Heikki Joensuu , Jean-Yves Blay , Alessandro Comandone , Javier Martin-Broto , Elena Fumagalli et al.
British Journal of Cancer, 2017, 117 (9), pp.1278-1285. ⟨10.1038/bjc.2017.290⟩
Journal articles hal-02301886v1

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.

Aurore Blesius , Philippe A Cassier , François Bertucci , Jérome Fayette , Isabelle Ray-Coquard et al.
BMC Cancer, 2011, 11, pp.72. ⟨10.1186/1471-2407-11-72⟩
Journal articles hal-00779604v1
Image document

Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial

Elise Bonnet , Véronique Haddad , Stanislas Quesada , Kim-Arthur Baffert , Audrey Lardy-Cléaud et al.
Journal of Personalized Medicine, 2022, 12, pp.1595. ⟨10.3390/jpm12101595⟩
Journal articles hal-03915443v1

Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibody

Angélique Gougelet , Adeline Mansuy , Jean-Yves Blay , Laurent Alberti , Claudine Vermot-Desroches et al.
PLoS ONE, 2009,
Journal articles inserm-03024083v1

CD4 lymphopenia to identify end-of-life metastatic cancer patients.

Julien Péron , Claire Cropet , Olivier Tredan , Thomas Bachelot , Isabelle Ray-Coquard et al.
European Journal of Cancer, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
Journal articles inserm-00875714v1

Increasing coverage rates for mammographic screening in France in older women--16 years of follow-up.

Francois Eisinger , François G. E. Beck , Jerome Viguier , Jean-Yves Blay , Yvan Coscas et al.
Breast Journal, 2011, 17 (6), pp.686-8. ⟨10.1111/j.1524-4741.2011.01169.x⟩
Journal articles istex hal-00811566v1

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

Manuarii Manuel , Olivier Tredan , Thomas Bachelot , Gilles Clapisson , Anais Courtier et al.
OncoImmunology, 2012, 1 (4), pp.432-440
Journal articles hal-00724448v1

Primary cardiac sarcomas: A retrospective study of the French Sarcoma Group.

Nicolas Isambert , Isabelle Ray-Coquard , Antoine Italiano , Maria Rios , Pierre Kerbrat et al.
European Journal of Cancer, 2013, epub ahead of print. ⟨10.1016/j.ejca.2013.09.012⟩
Journal articles hal-00875589v1
Image document

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

Alice Bonneville-Levard , Didier Frappaz , Olivier Tredan , Emilie Lavergne , Véronique Corset et al.
Medical Oncology, 2021, 39 (1), pp.4. ⟨10.1007/s12032-021-01536-4⟩
Journal articles hal-03915456v1

The off-label use of targeted therapies in sarcomas: the OUTC’S program

Lauriane Eberst , Claire Cropet , Axel Le Cesne , Patricia Pautier , Nicolas Penel et al.
BMC Cancer, 2014, 14 (1), pp.870. ⟨10.1186/1471-2407-14-870⟩
Journal articles hal-03623753v1
Image document

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

Emmanuelle Bompas , Loïc Campion , Antoine Italiano , Axel Le Cesne , Christine Chevreau et al.
Cancer Medicine, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩
Journal articles hal-01978221v1

Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study

Mathias Neron , Christophe Sajous , Simon Thezenas , Sophie Piperno-Neumann , Fabien Reyal et al.
Annals of Surgical Oncology, 2019, ⟨10.1245/s10434-019-08097-x⟩
Journal articles hal-02530556v1
Image document

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.

François Ghiringhelli , Cédric Ménard , Magali Terme , Caroline Flament , Julien Taieb et al.
Journal of Experimental Medicine, 2007, 202 (8), pp.1075-85. ⟨10.1084/jem.20051511⟩
Journal articles pasteur-00020140v1

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors.

Jean-Yves Blay , David Pérol , A. Le Cesne
Annals of Oncology, 2012, 23 (7), pp.1659-65. ⟨10.1093/annonc/mdr622⟩
Journal articles hal-00860391v1

Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome

Ataaillah Benhaddou , Laetitia Gaston , Gaëlle Pérot , Nelly Desplat , Laura Leroy et al.
Scientific Reports, 2021, 11 (1), pp.23429. ⟨10.1038/s41598-021-02787-x⟩
Journal articles hal-04094594v1

Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas

Elodie Darbo , Gaëlle Pérot , Lucie Darmusey , Sophie Le Guellec , Laura Leroy et al.
Cancers, 2023, 15 (2), pp.534. ⟨10.3390/cancers15020534⟩
Journal articles hal-04094632v1

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

Nicolas Penel , Axel Le Cesne , Sylvie Bonvalot , Antoine Giraud , Emmanuelle Bompas et al.
European Journal of Cancer, 2017, 83, pp.125-131. ⟨10.1016/j.ejca.2017.06.017⟩
Journal articles hal-03623713v1

De l’eau au moulin de thérapies ciblant l’interleukine-6 dans les tumeurs épithéliales

Angélique Gougelet , Adeline Mansuy , Jean-Yves Blay
médecine/sciences, 2008, 24 (8-9), pp.694-696. ⟨10.1051/medsci/20082489694⟩
Journal articles inserm-02532853v1
Image document

Best practices for the management of local-regional recurrent chordoma: a position paper by the chordoma global consensus group

A. Gronchi , P. Fossati , T. Akiyama , C. Alapetite , M. Baumann et al.
Annals of Oncology, 2017, Annals of oncology official journal of the European Society for Medical Oncology, 28, pp.1230-1242. ⟨10.1093/annonc/mdx054⟩
Journal articles hal-02639001v1
Image document

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

David Tougeron , Maxime Hentzien , Barbara Seitz-Polski , Firouze Bani-Sadr , Jean Bourhis et al.
European Journal of Cancer, 2021, 150, pp.232-239. ⟨10.1016/j.ejca.2021.03.030⟩
Journal articles hal-03225104v1

[Edifice program: analysis of screening exam practices for cancer in France]

Jean-Yves Blay , François Eisinger , Olivier Rixe , Anne Calazel-Benque , Jean-François Morère et al.
Bulletin du Cancer, 2008, 95 (11), pp.1067-73. ⟨10.1684/bdc.2008.0747⟩
Journal articles inserm-00483422v1

Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis

Nicolas Penel , Sylvie Bonvalot , André-Michel Bimbai , Alexandra Meurgey , François Le Loarer et al.
Clinical Cancer Research, 2022, 28 (18), pp.4105-4111. ⟨10.1158/1078-0432.CCR-21-4235⟩
Journal articles hal-03925659v1